Upcoming Financial Results Release for STRATA Skin Sciences
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leading medical technology company specializing in dermatologic treatments, is gearing up to reveal its financial results for the second quarter of 2025. The announcement is scheduled for the evening of August 13, 2025, right after market hours.
Details of the Financial Announcement
Management at STRATA will follow up the financial results announcement with a conference call aimed at reviewing the key outcomes and sharing insights into corporate developments. This call is set for 4:30 p.m. ET on the same day. Participants can expect a comprehensive overview of the financial status and strategic directions of the company.
How to Participate in the Conference Call
Those interested in participating in this informative session are encouraged to dial 1-866-524-3160 if calling domestically or 1-412-317-6760 for international participation. It's recommended to join the call about 10 minutes early to ensure connectivity and to express interest in the STRATA Skin Sciences conference.
Accessing the Live Webcast
Additionally, STRATA plans to provide a live webcast of the conference call, allowing broader access to interested stakeholders. Participants can join via this link.
Replay Information
For those unable to join live, a telephonic replay will be available until August 20, 2025, by calling 1-877-344-7529 (or 1-412-317-0088 for international calls) using the access code 4200962. Furthermore, a webcast replay will be accessible about one hour after the live event, remaining online until February 13, 2026.
About STRATA Skin Sciences, Inc.
STRATA is dedicated to advancing medical technology, focusing on innovative solutions for the in-office treatment of various dermatological conditions including psoriasis, vitiligo, and acne. Its flagship products encompass the XTRAC excimer laser and TheraClear X Acne Therapy System which deliver cutting-edge care to patients.
Unique Partnership Program
The company offers its technologies through a unique Partnership Program, which includes a fee-per-treatment cost structure rather than requiring upfront equipment purchases. This approach not only eases financial burdens on practices but also provides robust training and support.
Investor Engagement
The importance of investor relations is underscored by STRATA’s commitment to transparency and open communication. Investors and interested parties can reach out to the company for more details or inquiries regarding their products and financial standing.
Contact Information
For further information, investors are encouraged to contact STRATA's investor relations team at CORE IR by calling 516-222-2560 or emailing IR@strataskin.com. The company's official site also serves as a resource for updates and announcements.
Frequently Asked Questions
When will STRATA Skin Sciences announce its Q2 results?
The financial results for Q2 2025 will be announced on August 13, 2025.
How can I join the STRATA conference call?
Participants can call 1-866-524-3160 domestically or 1-412-317-6760 internationally starting at 4:30 p.m. ET on the announcement day.
Will the conference call be available after it airs?
Yes, there will be a telephonic replay available until August 20, 2025, and a webcast replay available for a longer period.
What is STRATA’s main focus?
STRATA specializes in developing and commercializing technology for treating dermatological issues, emphasizing innovative treatment solutions.
Who should I contact for investor inquiries?
Investors can reach out to CORE IR at 516-222-2560 or via email at IR@strataskin.com for any investor-related questions.
